• Bull.

    HEDGEYE'S DEAL OF THE MONTH

    TRY OUR DAILY MACRO PLAYBOOK

    FREE FOR 30 DAYS!

Takeaway: ALGN's Invisalign is vulnerable to Quad 3 in more ways than one...

SHORT ALIGN TECHNOLOGY (ALGN); QUAD 3 VULNERABILITY

Our Healthcare team is hosting a call on their new Best Idea Short Align Technology (ALGN) on Tuesday, July 2nd at 2:00 PM ET to show why this company is vulnerable in the current Quad 3 environment. 

Click here to get access.

CALL INVITE -> Adding Align Technology as Best Idea Short - 10.05.2022 it became a short cartoon

We think ALGN is a good short heading into 2H24 for a number of reasons.  We've been looking for ways to get more exposed to discretionary medical spending on the short side, expanding from EYE, which we've been short for some time, with the recent addition of PDCO.   Our data suggests continued softness in ALGN's North American GP utilization heading into 2Q24 and slight miss in 2Q24 revenue, a decent catalyst for the short, especially after the company recently raised guidance for 2024.  ALGN shares correlate strongest with EPS estimates with a seemingly hard floor of 20X forward P/E. We expect a softer outlook for 2H24, rising macro concerns, and lower estimates for 2025 can break the 20X floor and push ALGN below $200, or 20% lower from here.

We invite you to join us for this call.